Cargando…
Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523870/ https://www.ncbi.nlm.nih.gov/pubmed/36185302 http://dx.doi.org/10.3389/fonc.2022.997404 |
| _version_ | 1784800383000903680 |
|---|---|
| author | Mountzios, Giannis Banna, Giuseppe Luigi Rolfo, Christian |
| author_facet | Mountzios, Giannis Banna, Giuseppe Luigi Rolfo, Christian |
| author_sort | Mountzios, Giannis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9523870 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95238702022-10-01 Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways Mountzios, Giannis Banna, Giuseppe Luigi Rolfo, Christian Front Oncol Oncology Frontiers Media S.A. 2022-09-16 /pmc/articles/PMC9523870/ /pubmed/36185302 http://dx.doi.org/10.3389/fonc.2022.997404 Text en Copyright © 2022 Mountzios, Banna and Rolfo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Mountzios, Giannis Banna, Giuseppe Luigi Rolfo, Christian Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways |
| title | Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways |
| title_full | Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways |
| title_fullStr | Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways |
| title_full_unstemmed | Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways |
| title_short | Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways |
| title_sort | editorial: beyond chemotherapy and immunotherapy in thoracic malignancies: overcoming resistance by tackling new molecular pathways |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523870/ https://www.ncbi.nlm.nih.gov/pubmed/36185302 http://dx.doi.org/10.3389/fonc.2022.997404 |
| work_keys_str_mv | AT mountziosgiannis editorialbeyondchemotherapyandimmunotherapyinthoracicmalignanciesovercomingresistancebytacklingnewmolecularpathways AT bannagiuseppeluigi editorialbeyondchemotherapyandimmunotherapyinthoracicmalignanciesovercomingresistancebytacklingnewmolecularpathways AT rolfochristian editorialbeyondchemotherapyandimmunotherapyinthoracicmalignanciesovercomingresistancebytacklingnewmolecularpathways |